Autopsy report · NCT01130376

Novel Interventions in HIV-1 Infection

“Data from the 12 patients recruited has now been analysed, and it has been determined that it is sufficient to meet the study objectives.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 8 months after it had already started.
• Ran for about 2 years 1 month before it stopped.
• 12 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 1

Sponsor

Imperial College London

Sponsor type

University, hospital or other

Conditions

HIV-1 Infection

Interventions

GTU-MultiHIV B clade vaccine1mg; Interleukin-2; GM-CSF; Growth Hormone

Participants

12

Sites

1

Countries

United Kingdom

Trials that died the same way

• Combination of 5-azacitidine and Lenalidomide in Myelodysplastic Syndromes (MDS) or Acute Myelogenous Leukemia (AML) Myelodysplastic Syndromes
  “The primary objective has already been answered with the number of recruited patients.” (79% match in meaning)
• An Assessment of Voriconazole Pharmacokinetics and Pharmacogenetics in Liver Transplant Recipients - Pilot Study
  “Enrolled requested number of patients and completed study. In analysis” (72% match in meaning)
• Vorinostat Plus FND in Relapsed or Refractory Mantle Cell Lymphoma
  “we collected data of a total of 19 patients for an interim analysis. but there are less than 7 responses out of the initial 19 patients.” (65% match in meaning)
• Trial Comparing Start Stimulation of Recombinant Follicle Stimulating Hormone (rFSH) on Cycle Day 2 Versus Cycle Day 5 in In Vitro Fertilization (IVF)
  “Inclusion of the study didn't go as fast as expected. Expect: 234 patients in 1 year in 2 centers. After 1,5 year only 147 patients were recruited.” (64% match in meaning)
• Clinical, Electrophysiological and Biological Diagnostic Criteria of Sensory Neuronopathies
  “Start of a new study concerning the same patients” (62% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.